Development of the inhibition therapy against growth and metastasis of oral cancer targeting CXC chemokine, SDF-1
| Project/Area Number |
21792003
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
UCHIDA Daisuke The University of Tokushima, 大学院・ヘルスバイオサイエンス研究部, 助教 (20335798)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | SDF-1 / CXCR4 / 口腔癌 / 転移 / CXCR7 / AMD3100 |
|---|
| Research Abstract |
We have tried to inhibit both growth via CXCR7 and metastasis via CXCR4 by the inhibition of SDF-1 on the oral cancer cells. SDF-l antibody inhibited the anchorage independent growth of oral cancer cells in vitro, but did affect neither growth nor metastasis in vivo. However, a CXCR4 specific antagonist AMD3100 significantly inhibited the metastasis of oral cancer cells. These results indicated that inhibition of both CXCR4 and CXCR7 by the SDF-1 antibody is difficult, but AMD3100 may be a potent anti-metastatic therapy in cases of CXCR4-related oral cancer.
|
Report
(3 results)
Research Products
(5 results)
